Battling For Health → Addiction • Alzheimer • Arthritis • Cancer • Depression • Diabetes • Healthcare • Heart • M.S. • Obesity • Schizo • Stress • Vision
Archive for November, 2006
By Michael Russell
In our first article in this series on multiple sclerosis we discussed what the disease itself was. In this articles we’re going to go over the different types of multiple sclerosis.
There are actually four different variations of multiple sclerosis. This was defined by an independent survey of neurologists in 1996.
By Groshan Fabiola
Multiple sclerosis is a disease of the central nervous system that makes it attack the myelin, a substance that protects the nerve endings that are spread throughout the entire body. The central nervous system is responsible for sending the white blood cells and the antibodies attack the viruses and bacteria that threaten to cause infections. When the nervous system is affected by multiple sclerosis it sends these guardian cells against the myelin. The cause of this behavior is not known yet but the scientist believe that it is sometimes genetically-based.
Multiple sclerosis affects more than a million people throughout the world and unfortunately there is no known treatment that can cure it. The only thing that multiple sclerosis therapy can do is to relive its symptoms and modify the way the illness advances and develops.
By Groshan Fabiola
According to recently conducted experiments, cannabis can be considered an effective remedy for patients diagnosed with multiple sclerosis. While at first the symptomatic improvements experienced by patients with multiple sclerosis who have been administered cannabinoid products were thought to be determined solely by psychological factors, later research has revealed that cannabis actually reduces muscular spasms and stiffness characteristic to multiple sclerosis sufferers. The benefic effects of cannabis on patients with multiple sclerosis have been confirmed by short-term and long-term controlled medical studies.
In 2003, a team of researchers from the Peninsula Medical School in Exeter, UK have made public the results of a series of short-term and long-term studies on the effects of cannabinoids among patients with multiple sclerosis. The previously conducted studies involved the active participation of around 600 patients with advanced-stage multiple sclerosis. The participants were divided in two distinctive groups: the first group received cannabinoid compounds in equal doses, while the second group received placebo medications over a period of 15 weeks. By the end of the experiment, the majority of patients who were administered cannabinoids experienced considerable symptomatic improvements, having less muscular pain and being confronted with milder muscular spasticity (less pronounced muscular spasm). Unlike the group that received cannabinoid compounds over the entire period of the study, the control group (patients who received placebo medications) experienced no improvements in their overall condition.
By Groshan Fabiola
Despite the fact that there is no specific cure for multiple sclerosis in present, existing treatments are effective in slowing down the progression rate of the disease and preventing the development of further complications. Considering the fact that most of the effects of multiple sclerosis are irreversible, it is imperative to timely diagnose the disease and begin the administration of the appropriate course of medications. With the right treatment and with the aid of supportive therapies (physiotherapy and kinetotherapy), patients with multiple sclerosis can regain control of their bodies and live normal, active lives.
The medications available today are used to accomplish a series of goals in patients with multiple sclerosis: some medication treatments are aimed at slowing the progression rate of the disease, while others are aimed at ameliorating its generated symptoms and prolonging the periods of remission. The medications that are nowadays extensively used to delay and control symptomatic flare-ups among patients with multiple sclerosis are known as “ABC drugs”. This category of medications consists of Avonex, Betaseron and Copaxone.
* Note: This post is a generic post being duplicated on all Battling-Series of blogs …
Blogger(s) Wanted
I am looking for individuals to write for each of the “Battling-Series” of blogs .. on a shared revenue basis. Bloggers will share in ad revenues generated by the site on an agreed formula (first $100 USD plus 60% of the excess). There is no guarantee of future earnings and these blogs are currently not earning any revenues at this time. However, I believe that the potential for future earnings is there.
If blogging for me sounds appealing to you ..
.. EMAIL >> hart (at) PetLvr (dot) com ..
.. with the following information:
Listed above is the Site URL and RSS Feed URL to our “Network #2 Blog” .. over at the HART-Empire Network … I hope you check it out!
HART-Empire Network II is our newest blog that reposts summaries and headlines from 100% of all blogs in our network. So, if you want to see it all in your Bloglines or other feed reader of choice … now all you need to choose is just one combined feed!
While it is true that there is no cure for M.S. yet, there are now FDA-approved medications that have been shown to modify or slow down the underlying course of M.S. In addition, many therapeutic and technological advances are helping people manage symptoms and lead productive lives ... More ..
Search the HART-Empire Network of sites, including this one, with the search form below.
Battling Multiple Sclerosis is Copyright © HART-Empire Network • Powered by WordPress
Original network template design by Thord Daniel Hedengren • HART'icized by HART (1-800-HART)
